ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,947 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaarCentenara Labs AG
Centenara Labs AG Logo
Verified· 2 sources

Centenara Labs AG

Summary

About the company

The core activity of Centenara Labs AG is the development and investment in therapies that combat age-related diseases such as cancer, muscle weakness, vision loss, and cognitive impairments. The company focuses on researching and developing medications that address the so-called "Hallmarks of Aging" to improve the health and well-being of older people and extend their lifespan.

AI-generated
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
✓ Offered8
Development and investment in therapies for age-related diseases
Development and investment in therapies for age-related diseases, expansion of a pipeline of therapeutics, supporting researchers in translating scientific discoveries into medicines.
Development of senescence therapeutics
Development of new approaches for the targeted removal of aging cells with applications in cancer, fibrosis and age-related diseases; preclinical pipeline with RejuverSen and RST programmes.
Development of telomer therapeutics
Development of therapies to restore telomere function in age-related disorders and rare genetic diseases; preclinical programme with CCT-001.
Development of vascular neurotherapeutics
Development of therapies to restore cerebral blood supply and improve CNS function in neurodegenerative and age-related diseases; discovery programme with CVT-001.
Building and investing in portfolio companies
Building portfolio companies with early therapeutics companies, co-founding with scientific entrepreneurs and investing in diversified projects.
Co-founding of therapeutics companies
Co-founding portfolio companies together with scientific entrepreneurs to turn ideas into medicines and accelerate development through to the clinic.
Partnerships for preclinical and clinical development
Collaboration with scientists and partners to bring research results to the clinic and speed up therapies.
Compliance & Governance
Corporate and process governance, Code of Conduct and behavioural standards for employees and cooperation partners.
Comparisons

Centenara Labs AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Centenara Labs AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Centenara Labs AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuhofstrasse 12
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-276.079.851
Founded
2019 · 7 years
Last commercial register change
March 21, 2025
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Centenara Labs AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AP
Alexion Pharma GmbH
Baar
BS
Biogen Switzerland AG
Baar
FS
FyoniBio SA
Baar
AP
A2A Pharma AG
Rotkreuz
AP
Aphaia Pharma AG
Zug
GS
G&L Scientific (Schweiz) GmbH
Zug
NT
Nektar Therapeutics Europe GmbH
Zug
AS
Apellis Schweiz GmbH
Zug